Crucial role of N-terminal residue of binding peptides in recognition of the monoclonal antibody specific for the peptide-HLA-B5, -B35 complex

Immunogenetics

Volumn 47, Issue 2, 1997, Pages 149-158

  Sakaguchi, Takashi ^a   Takamiya, Yuji ^a   Edidin, Michael ^d   Nokihara, Kiyoshi ^c   Miwa, Kiyoshi ^b   Schönbach, Christian ^a   Takiguchi, Masafumi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b AJINOMOTO CO INC   (Japan)

^c Bio Medical System   (Japan)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Antibody; Epitope; HLA class I; Peptide

Indexed keywords

ASPARAGINE; ASPARTIC ACID; GLUTAMIC ACID; HISTIDINE; HLA B ANTIGEN; MONOCLONAL ANTIBODY; PEPTIDE ANTIBODY; SERINE; TYROSINE; VALINE;

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ANTIGEN BINDING; ARTICLE; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0031974925     PISSN: 00937711     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002510050340     Document Type: Article

References (37)

1. Arnold, D., Driscoll, J., Androlewicz, M., Hoghes, E., Cresswell, P., and Spies, T. Proteasome subunits encoded in the MHC are not generally required for the processing of peptides bound by MHC class I molecules. Nature 362: 171-174, 1992
2. Barouch, D., Davenport, M., McMichael, A., and Reay, P. A mAb against HLA-A2 can be influenced both positively and negatively by the associated peptides. Int. Immunol 7: 1599-1605, 1995
3. Beck, Y., Satz, L., Takamiya, Y., Nakayama, S., Ling, L., Ishikawa, Y., Nagao, T., Uchida, H., Tokunaga, K., Müller, C., Juji, T., and Takiguchi, M. Polymorphism of human minor histocompatibility antigen: T cell recognition of human minor histocompatibility peptides presented by HLA-B35 subtype molecules. J Exp Med 181: 2037-2048, 1995
4. Bluestone, J. A., Jameson, S., Miller, S., and Dick II, R. Peptide-induced conformational changes in class I heavy chains alter major histocompatibility complex recognition. J Exp Med 176: 1757-1761, 1992
5. Bouvier, M. and Wiley, D. C. Importance of peptide amino and carboxyl termini to the stability to MHC class I molecules. Science 265: 398-402, 1994
6. Bowness, P., Allen, R. L., and McMichael, A. J. Identification of T cell receptor recognition residues for a viral peptide presented by HLA B27. Eur J Immunol 24: 2357-2362, 1994
7. Catipovic, B., Dal. Porto, J., Mage, M., Johansen, T. E., and Schneck, J. P. Major histocompatibility complex conformational epitopes are peptide specific. J Exp Med 176: 1611-1618, 1992
8. Catipovic, B., Talluri, G., Oh, J., Wei, T., Su, X.-M., Johansen, T. E., Edidin, M., and Schneck, J. P. Analysis of the structure of empty and peptide-loaded major histocompatibility complex molecules at the cell surface. J Exp Med 180: 1753-1761, 1994
9. Colbert, R. A., Rowland-Jones, S. L., McMichael, A. J., and Frelinger, J. A. Differences in peptide presentation between B27 subtypes: the importance of the P1 side chain in maintaining high affinity peptide binding to B*2703. Immunity I: 121-130, 1994
10. Due, H. T., Rucay, P., Righenzi, S., Halle-Pannenko, O., and Kourilsky, P. Monoclonal antibodies directed against T cell epitopes presented by class 1 MHC antigens. Int Immunol 5: 427-431, 1993
11. D'Urso, C. M., Wang, Z., Cao, Y., Tatake, R., Zeff, R. A., and Ferrone, S. Lack of HLA class I antigen expression by cultured melanoma cells EO-1 due to a defect in β2m gene expression. J Clin Invest 87: 284-292, 1991
12. Falk, K., Rötzschke, O., Takiguchi, M., Gnau, V., Stevanović, S., Jung, G., and Rammensee, H.-G. Peptide motifs of HLA-B51. -B52 and -B78 molecules, and implications for Beçhet's disease. Int Immunol 7: 223-228, 1995
13. Fukazawa, T., Wang, J., Huang, F., Wen, J., Tyan, D., Williams, K. M., Raybourne, R. B., and Yu, D. T. Y. Testing the importance of each residue in a HLA-B27 binding peptide using monoclonal antibodies. J Immunol 152: 1190-1196, 1994
14. Hayashi, H., Ennis, P. D., Ariga, H., Salter, R. D., Parham, P., Kano, K., and Takiguchi, M. HLA-B51 and HLA-Bw52 differ by only two amino acids which are in the helical region of the α1 domain. J Immunol 142: 306-311, 1989
15. Haynes, B. F., Reisner, E. G., Hemler, M. E., Strominger, J. L., and Eisenbarth, G. S. Description of a monoclonal antibody defining an HLA allotypic determinant that includes specificities within the B5 cross-reacting group. Hum Immunol 4: 273-285, 1982
16. Hogquist, K. A., Grandea III, A. G., and Bevan, M. J. Peptide variants reveal how antibodies recognize major histocompatibility complex class I. Eur J Immunol 23: 3028-3036, 1993
17. Kelly, A., Powis, S. H., Kerr, L.-A., Mockridge, I., Elliott, T., Bastin, J., Uchanska-Ziegler, B., Ziegler, A., Trowsdale, J., and Townsend, A. Assembly and function of the two ABC transporter proteins encoded in the human major histocompatibility complex. Nature 355: 641-644, 1992
18. Kikuchi, A., Sakaguchi, T., Miwa, K., Takamiya, Y., Rammensee, H.-G., Kaneko, Y., and Takiguchi, M. Binding of nonamer peptides to three HLA-B51 molecules which differ by a single amino acid substitution in the A-pocket. Immunogenetics 43: 268-276, 1996
19. Kuzushima, K., Sun, R., van Blee, G. M., Vegh, Z., and Nathenson, S. G. The role of self peptides in the allogeneic cross-reactivity of CTLs. J Immunol 155: 594-601, 1995
20. Nakayama, S., Kawaguchi, G., Karaki, S., Nagao, T., Uchida, H., Kashiwase, K., Akaza, T., Nasuno, T., and Takiguchi, M. Effect of single amino acid substitution at residue 167 of HLA-B51 on binding of antibodies and recognition of T cells. Hum Immunol 39: 211-219, 1994
21. Nokihara, K., Yamamoto, R., Hazama, M., Wakizawa, O., and Nakamura, S. Design and applications of a novel simultaneous multiple solid-phase peptide synthesizer. In Epton (ed.) Innovation and Perspectives in Solid-Phase Synthesis, p 445, Intercept, Andover, 1992
22. Ooba, T., Hayashi, H., Karaki, S., Tanabe, M., Kano, K., and Takiguchi, M. The structure of HLA-B35 suggests that it is derived from HLA-Bw58 by two genetic mechanisms. Immunogenetics 30: 76-80, 1989
23. Rötzschke, O., Falk, K., Faath, S., and Rammensee, H.-G. On the nature of peptide involved in T cell alloreactivity. J Exp Med 174: 1059-1071, 1991
24. Sakaguchi, T., Ibe, M., Miwa, K., Kaneko, Y., Yokota, S., Tanaka, K., and Takiguchi, M. Binding of 8-mer to 11-mer peptides carrying the anchor residues to slow assembling HLA class I molecules, HLA-B*5101. Immunogenetics 45: 259-265, 1997
25. Schönbach, C., Ibe, M., Shiga, H., Takamiya, Y., Miwa, K., Nokihara, K., and Takiguchi, M. Fine tuning of peptide binding to HLA-B*3501 molecules by nonanchor residues. J Immunol 154: 5951-5958, 1995
26. Schönbach, C., Miwa, K., Ibe, M., Shiga., H., Nokihara, K., and Takiguchi, M. Refined peptide-HLA-B*3501 binding motif reveals differences between 10-mer and 11-mer peptide binding. Immunogenetics 45: 121-129, 1996
27. Schreiber, A. B., Schlessinger, J., and Edidin, M. Interaction between major histocompatibility complex antigens and epidermal growth factor receptors on human cells. J Cell Biol 98: 725-731, 1984
28. Sherman, L. A., Chattopadhyay, S., Biggs, J. A., Dick II, R. F., and Bluestone, J. A. Alloantibodies can discriminate class I major histocompatibility complex molecules associated with various endogenous peptides. Proc Natl Acad Sci USA 90: 6949-6951, 1993
29. Smith, K. J., Reid, S. W., Harlos, K., McMicahel, A. J., Stuart, D. I., Bell, J. I., and Jones, E. Y. Bound water structure and polymorphic amino acids act together to allow the binding of different peptides to MHC class I HLA-B53. Immunity 4: 215-228, 1996
30. Solheim, J. C., Carreno B. M., Myers N. B., Lee D. R., and Hansen T. H. Peptide-induced rescue of serologic epitopes on class I MHC molecules. J Immunol 154: 1188-1197, 1995
31. Spies, T. and DeMars, R. Restored expression of major histocompatibility class I molecules by gene transfer of a putative peptide transfer. Nature 351: 323-324, 1991
32. Takamiya, Y, Schönbach, C., Nokihara, K., Ferrone, S., and Takiguchi, M. HLA-B*3501-peptide interactions: role of anchor residues of peptides in their binding to HLA-B*3501 molecules. Int Immunol 6: 225-261, 1994
33. Takamiya, Y., Sakaguchi, T., Miwa, K., and Takiguchi, M. Role of HLA-B*5101 binding nonamer peptides in formation of the HLA-Bw4 public epitope. Int Immunol 8: 1027-1034, 1996
34. Takiguchi, M., Kawaguchi, G., Sekimata, M., Hiraiwa, M., Kariyone, A., and Takamiya, Y. The role of conserved residue in pockets A and polymorphic residue in pocket E of HLA-B*3501 in presentation of human minor histocompatibility peptides to T cells. Int Immunol 6: 1345-1352, 1994
35. Tallquist, M. D., Yun, T. J., and Pease, L. R. A single T cell receptor recognizes structurally distinct MHC/peptide complexes with high specificity. J Exp Med 184: 1017-1026, 1996
36. Tanabe, M., Sekimata, M., Ferrone, S., and Takiguchi, M. Structural and functional analysis of monomorphic determinants recognized by monoclonal antibodies reacting with the HLA class I α3 domain. J Immunol 148: 3202-3209, 1992
37. Wang, J., Yu, D. T. Y., Fukazawa, T., Kellner, H., Wen, J., Cheng, X.-K., Roth, G., Williams, K. M., and Raybourne, R. B. A monoclonal antibody that recognizes HLA-B27 in the context of peptides. J Immunol 152: 1197-1205, 1994